Enalapril and Felodipine
Pronunciation
(e NAL a pril & fe LOE di peen)
U.S. Brand Names
Lexxel®
Synonyms
Felodipine and Enalapril
Generic Available
No
Canadian Brand Names
Lexxel®
Use
Treatment of hypertension, however, not indicated for initial treatment of hypertension; replacement therapy in patients receiving separate dosage forms (for patient convenience); when monotherapy with one component fails to achieve desired antihypertensive effect, or when dose-limiting adverse effects limit upward titration of monotherapy
Pregnancy Risk Factor
C/D (2nd and 3rd trimesters)
Pregnancy Implications
Refer to Enalapril monograph.
Lactation
Enters breast milk/use caution
Adverse Reactions
See individual agents.
Drug Interactions
Enalapril: Substrate of CYP3A4 (major)
Felodipine: Substrate of CYP3A4 (major); Inhibits CYP2C8/9 (weak), 2D6 (weak), 3A4 (weak)
Also see individual agents.
Mechanism of Action
See individual agents.
Pharmacodynamics/Kinetics
See individual agents.
Dosage
Adults: Oral: 1 tablet daily
Patient Education
See individual agents.
Pregnancy/breast-feeding precautions: Inform prescriber if you are or intend to become pregnant. Consult prescriber if breast-feeding.
Cardiovascular Considerations
Combination therapy for the treatment of hypertension should be individualized for each patient. Potential advantages for enalapril and felodipine combination therapy may include improved compliance and synergistic reductions in blood pressure with an accompanied reduction in side effects. ACE inhibitors are standard therapy for left ventricular systolic dysfunction. Felodipine has neutral effects on mortality in this setting and therefore may be considered for the treatment of hypertension or angina in patients with heart failure.
Dental Health: Effects on Dental Treatment
Key adverse event(s) related to dental treatment: Gingival hyperplasia (fewer reports with felodipine than with other CCBs); resolves upon discontinuation (consultation with physician is suggested).
Dental Health: Vasoconstrictor/Local Anesthetic Precautions
No information available to require special precautions
Mental Health: Effects on Mental Status
May cause drowsiness and dizziness; rarely may cause nervousness, insomnia, confusion, or depression
Mental Health: Effects on Psychiatric Treatment
May rarely cause agranulocytosis; use caution with clozapine and carbamazepine; may decrease lithium clearance resulting in an increase in serum lithium levels and potential lithium toxicity; monitor serum lithium levels; carbamazepine may decrease felodipine effect
Dosage Forms
Tablet, extended release:
Enalapril maleate 5 mg and felodipine 2.5 mg
Enalapril maleate 5 mg and felodipine 5 mg
References
Chobanian AV, Bakris GL, Black HR, et al, "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report,"JAMA, 2003, 289(19):2560-71.
"Consensus Recommendations for the Management of Chronic Heart Failure. On Behalf of the Membership of the Advisory Council to Improve Outcomes Nationwide in Heart Failure,"Am J Cardiol, 1999, 83(2A):1A-38A.
Kaplan NM and Sever PS, "Combination Therapy: A Key to Comprehensive Patient Care,"Am J Hypertens, 1997, 10(7 Pt 2):127S.
Moser M and Black HR, "The Role of Combination Therapy in the Treatment of Hypertension,"Am J Hypertens, 1998, 11(6 Pt 2):73S-8S, 95S-100S.
International Brand Names
Lexxel® (CA)